Development of hot-melt extruded drug/polymer matrices for sustained delivery of meloxicam
Authors:
- 3 January 2022
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 342, 189-200
Abstract
No abstract availableKeywords
Funding Information
- Eli Lilly and Co
This publication has 37 references indexed in Scilit:
- Drug delivery system based on cyclodextrin-naproxen inclusion complex incorporated in electrospun polycaprolactone nanofibersColloids and Surfaces B: Biointerfaces, 2014
- Overcoming sink limitations in dissolution testing: a review of traditional methods and the potential utility of biphasic systemsJournal of Pharmacy and Pharmacology, 2012
- Thermal processing of a poorly water-soluble drug substance exhibiting a high melting point: The utility of KinetiSol® DispersingInternational Journal of Pharmaceutics, 2011
- Evaluating Exaggerated, Prolonged, or Delayed Postoperative Intraocular InflammationAmerican Journal of Ophthalmology, 2010
- Alginate-PLL cell encapsulation system Co-entrapping PLGA-microspheres for the continuous release of anti-inflammatory drugsBiomedical Microdevices, 2009
- Estimation of Drug–Polymer Miscibility and Solubility in Amorphous Solid Dispersions Using Experimentally Determined Interaction ParametersPharmaceutical Research, 2008
- Analysis of Microbial Community during Biofilm Development in an Anaerobic Wastewater Treatment ReactorMicrobial Ecology, 2007
- Safety and Efficacy of Disease-Modifying Anti-Rheumatic AgentsDrug Safety, 2002
- Pharmacology of Meloxicam, A New Non-Steroidal Anti-Inflammatory Drug with an Improved Safety Profile Through Preferential Inhibition of COX-2Rheumatology, 1996
- The Determination of Pore Volume and Area Distributions in Porous Substances. I. Computations from Nitrogen IsothermsJournal of the American Chemical Society, 1951